Jinpyo Hong Selected Research

M62812

10/2020

TAP2, a peptide antagonist of Toll-like receptor 4, attenuates pain and cartilage degradation in a monoiodoacetate-induced arthritis rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinpyo Hong Research Topics

Disease

9	Pain (Aches) 03/2021 - 06/2017
5	Neuralgia (Stump Neuralgia) 09/2019 - 01/2018
4	Glioblastoma (Glioblastoma Multiforme) 03/2020 - 02/2010
4	Neuroinflammatory Diseases 01/2020 - 09/2017
3	Neoplasms (Cancer) 07/2022 - 01/2017
3	Osteoarthritis 10/2020 - 09/2019
3	Hyperalgesia 09/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 07/2022 - 03/2020
2	Peripheral Nerve Injuries 01/2020 - 09/2019
2	Spasm (Spasms) 08/2019 - 05/2018
1	Mental Disorders (Mental Disorder) 01/2022
1	COVID-19 01/2022
1	Inflammation (Inflammations) 10/2020
1	Arthritis (Polyarthritis) 10/2020
1	Neoplasm Metastasis (Metastasis) 03/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2020
1	Crush Injuries 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Chronic Traumatic Encephalopathy 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Brain Neoplasms (Brain Tumor) 05/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Schizophrenia (Dementia Praecox) 01/2017
1	Brain Diseases (Brain Disorder) 12/2016
1	Alzheimer Disease (Alzheimer's Disease) 08/2014
1	Infectious Skin Diseases 01/2012
1	Pruritus (Itching) 01/2012
1	Necrosis 11/2008

Drug/Important Bio-Agent (IBA)

3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 06/2017
3	Toll-Like Receptor 4IBA 10/2020 - 01/2018
3	Small Interfering RNA (siRNA)IBA 03/2020 - 01/2018
3	N-Methylaspartate (NMDA)IBA 08/2019 - 06/2017
2	Formaldehyde (Formol)FDA Link 03/2021 - 06/2017
2	Peptides (Polypeptides)IBA 10/2020 - 06/2019
2	CytokinesIBA 10/2020 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 06/2019
2	Analgesics (Analgesic Drugs)IBA 09/2019 - 06/2019
2	NeurotoxinsIBA 01/2019 - 12/2016
2	Antipsychotic Agents (Antipsychotics)IBA 05/2018 - 01/2017
2	Trifluoperazine (Stelazine)FDA LinkGeneric 05/2018 - 01/2017
2	Caffeine (No Doz)FDA LinkGeneric 01/2017 - 02/2010
2	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2017 - 02/2010
2	CalciumIBA 01/2017 - 02/2010
1	Phenobarbital (Luminal)FDA Link 07/2022
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	human ERBB2 proteinIBA 07/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2022
1	RNA (Ribonucleic Acid)IBA 07/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	TOR Serine-Threonine KinasesIBA 03/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2021
1	M62812IBA 10/2020
1	Matrix Metalloproteinases (MMPs)IBA 03/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 03/2020
1	A 19IBA 03/2020
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 03/2020
1	Caspase 3 (Caspase-3)IBA 03/2020
1	Cyclin B1IBA 03/2020
1	ArginaseIBA 01/2020
1	SteroidsIBA 01/2020
1	Myelin Basic ProteinIBA 01/2020
1	Evans Blue (Blue, Evans)FDA Link 09/2019
1	Adenosine Triphosphate (ATP)IBA 09/2019
1	Purinergic Receptors (Receptors, Purine)IBA 09/2019
1	Betamethasone (Celestone)FDA Link 08/2019
1	Hypoxia-Inducible Factor 1IBA 01/2019
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2019
1	Biological ProductsIBA 05/2018
1	LipopolysaccharidesIBA 09/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2017
1	EndotoxinsIBA 12/2016
1	gamma-Aminobutyric Acid (GABA)IBA 08/2014
1	Toll-Like Receptor 7IBA 01/2012
1	Imiquimod (Aldara)FDA LinkGeneric 01/2012
1	Potassium Channels (Potassium Channel)IBA 01/2012
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 02/2010
1	Inositol (Myoinositol)IBA 02/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2008
1	InterleukinsIBA 11/2008

Therapy/Procedure

4	Ligation 09/2019 - 01/2018
2	Therapeutics 10/2020 - 02/2010
1	Intra-Articular Injections 10/2020
1	Conservative Treatment 01/2020
1	Spinal Injections 09/2019
1	Adjuvant Chemotherapy 05/2018